Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial

BACKGROUND: Updated vaccine strategies are needed to protect against new SARS-CoV-2 variants with increased immune escape. Here, information on the safety and immunogenicity of an inactivated Omicron-adapted vaccine is presented, as compared with CoronaVac. METHODS: A randomized, double-blind, activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jialei, Liu, Yueyue, Liu, Shuo, Shu, Qun, Yang, Xuenan, Chu, Kai, Qiao, Yaping, Hu, Yaling, Wang, Kaiqin, Pan, Hongxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548824/
https://www.ncbi.nlm.nih.gov/pubmed/37799724
http://dx.doi.org/10.3389/fimmu.2023.1241153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548824/
https://www.ncbi.nlm.nih.gov/pubmed/37799724
http://dx.doi.org/10.3389/fimmu.2023.1241153

Ejemplares similares